Imc-Chicago 13F: Cuts Align Technology (ALGN) Stake by $4.5M
Imc-Chicago cut its holdings in Align Technology by 25,422 shares, a 67% decrease.
Reviewed by automated data checks against the source filing. How we make and check alerts
Imc-Chicago sold 25,422 shares from its stake in Align Technology, Inc. ($ALGN), a 66.95% decrease, according to a 13F filing with the SEC dated May 5, 2026. It reported 12,551 shares worth $2.24 million at the end of the quarter.
Since the filing, $ALGN is down 1.7% after 1 week, down 0.2% after 1 month and down 12.7% to date (from the $168.71 close on May 5, 2026).
ALGN
Align Technology, Inc.
Key Points
- Imc-Chicago reduced its stake in Align Technology by 25,422 shares, leaving 12,551 shares valued at $2.29 million as of the latest 13F filing.
- Shares of Align Technology traded at $182.08 with a market cap of $13.04 billion and a P/E ratio of 30.65.
- Insiders at Align Technology were active, with several buying and selling shares, while analysts set new price targets ranging from $188 to $240.
Get $ALGN trade alerts by text
We text you when insiders, Congress or big funds trade $ALGN. Free.
Not investment advice. TradeTexts is not a registered investment adviser, and this automated Align Technology, Inc. alert may contain errors. Disclosures
Imc-Chicago has significantly reduced its position in Align Technology, Inc. (NasdaqGS: ALGN), as revealed in its latest Form 13F filing with the SEC. The firm cut its holdings by 25,422 shares, a 67% decrease, leaving it with 12,551 shares valued at approximately $2.29 million. This filing reflects holdings as of the reporting period and may not represent Imc-Chicago's current position.
Imc-Chicago vs. the S&P 500
Hypothetical returns from Imc-Chicago's disclosed trades, not real profit or advice. How we model this.
What Changed in Imc-Chicago's Align Technology Position
Imc-Chicago's decision to cut its stake in Align Technology resulted in a reduction from 37,973 shares to 12,551 shares, marking a decrease of 25,422 shares or about 67%. The remaining shares are valued at about $2.29 million, based on the spot price of $182.08.
Other Institutional Activity in Align Technology
Other major funds have also adjusted their positions in Align Technology. Vanguard Capital Management LLC added 4,389,119 shares, bringing its total to 4,389,119 shares valued at approximately $752.43 million. BlackRock, Inc. trimmed its holdings by 70,636 shares, ending with 4,289,924 shares worth about $735.42 million. Capital World Investors significantly increased its stake by 2,581,793 shares, now holding 4,072,296 shares valued at $698.11 million. Meanwhile, Capital International Investors reduced its holdings by 834,019 shares to 3,809,202 shares, valued at $653.01 million.
Align Technology, Inc. Stock Up 20.9%
Shares of Align Technology currently trade near $182.08. The company has a market cap of about $13.04 billion and a P/E ratio of 30.65, with a forward P/E of 14.72. Its beta is 1.671, indicating higher volatility compared to the broader market. The stock's 52-week range has seen a low of $122.00 and a high of $208.31. The 50-day moving average stands at $173.86, while the 200-day moving average is $160.18.
Recent Earnings
Align Technology reported revenue of approximately $4.10 billion, reflecting a growth rate of 6.2%. The company's net margin is 10.5%, with a return on equity (ROE) of 10.8%. Earnings per share (EPS) were reported at $5.94. The next earnings report is scheduled for July 29, 2026.
Earnings drift grade
Outlook vs expectations on the last report — not price action.
-
Forward outlook
1 analysts raised price targets.
-
EPS & revenue
EPS beat estimates by 11.0%. Revenue met estimates.
-
Profit surprise
EBITDA missed by 36 percent. Operating income missed by 13 percent.
-
Pre-earnings setup
Expectations were about average.
-
Analyst signal
1 target raise.
-
Earnings quality
Gross margin up 1.4 points. Operating margin up 3.2 points. Positive free cash flow.
Earnings Call Summary
Align reported $1.041 billion in Q1 revenue, up 6.2 percent, with record clear aligner shipments of 686,000 cases. Growth was driven by strong international performance, particularly in EMEA and APAC with double-digit volume increases, while North America remained stable. Management attributed near-term caution to Middle East conflict uncertainty and ongoing macro headwinds affecting consumer demand, but emphasized long-term confidence in digital orthodontics and restorative dentistry expansion through new products like the Invisalign palate expander and treatment planning services.
Guidance Management reaffirmed full year revenue growth of 3 percent to 4 percent and clear aligner volume growth in mid-single digits. They expect Q2 revenue of $1.040 billion to $1.060 billion, up 3 percent to 5 percent year-over-year, with clear aligner volumes up both sequentially and year-over-year.
Slightly positive report. The quarter was acceptable, but the forward setup is not strong.
Insider Buying and Selling at Align Technology, Inc.
Recent insider transactions at Align Technology included various activities on May 20, 2026. Kevin Conroy acquired 1,836 shares, while Poul Mojdeh sold 1,745 shares but also bought 1,836 shares. Susan Siegel purchased 1,745 shares, and Raymond Larkin Jr. added 2,448 shares to his holdings. Britt Vitalone sold 1,443 shares.
Analysts Set New Price Targets
Analysts have updated their ratings and price targets for Align Technology. On April 30, 2026, Evercore ISI Group maintained a 'buy' rating with a target of $220. Morgan Stanley, on April 24, maintained a 'hold' rating with a target of $188. Piper Sandler reiterated a 'buy' rating with a target of $235 on April 21. Citigroup initiated coverage with a 'buy' rating and a $240 target on April 15. The consensus recommendation is a 'buy', with a mean target price of $209.07 across 14 analyst opinions.
About Align Technology
Align Technology, Inc. specializes in medical instruments and supplies, primarily known for its Invisalign clear aligners and iTero intraoral scanners. Headquartered in Tempe, Arizona, the company operates in the healthcare sector, providing innovative orthodontic products and services worldwide. Led by CEO Joseph M. Hogan, Align Technology employs over 20,000 people and continues to expand its product offerings in digital orthodontics and restorative dentistry.
Bottom Line
Imc-Chicago's substantial reduction in Align Technology shares highlights the dynamic nature of institutional investment strategies. Investors closely watch such filings to gauge institutional sentiment, though these reports are backward-looking and may not reflect current positions. Align Technology remains a significant player in the healthcare sector, with ongoing interest from both analysts and institutional investors.
Related Filing Alerts
Source: Imc-Chicago's 13F filing on $ALGN (May 5, 2026). 13F filings show holdings as of the end of the reporting quarter and may not reflect the fund's current position. Find the original filing: Imc-Chicago 13F filings on SEC EDGAR. Written by software, not financial advice. How we make alerts